Clinical Edge Journal Scan

Depressive and endothelial dysfunction in PsA: Is there a link?


 

Key clinical point: Endothelial dysfunction (ED) was inversely correlated with the severity of depressive symptoms in patients with psoriatic arthritis (PsA).

Major finding: Overall, 40% of PsA patients experienced depressive symptoms according to the Hospital Anxiety and Depression Scale (HDS). ED as measured by flow-mediated dilatation was negatively correlated with HDS score (Pearson’s coefficient [ ρ] 0.339; P = .016), intensity of pain, and disease activity in PsA score (both ρ, 0.507; P = .001).

Study details: Findings are from a cross-sectional study including 50 patients with PsA between 30 and 75 years of age and without any previous history of heart disease or diabetes.

Disclosures: No information on funding was available. The authors declared no conflicts of interest.

Source: De Lorenzis E et al. Front Med. 2021 Aug 27. doi: 10.3389/fmed.2021.669397 .

Recommended Reading

Secukinumab therapy against plaque psoriasis yields high patient satisfaction
MDedge Dermatology
Psoriasis exhibits a strong causal relationship with psychiatric diseases
MDedge Dermatology
Proton pump inhibitors likely promote psoriasis development
MDedge Dermatology
European agency recommends two new adalimumab biosimilars
MDedge Dermatology
Risk of developing PsA significantly lower in psoriasis patients treated with biologics
MDedge Dermatology
Affected body surface area predicts risk of PsA in patients with psoriasis
MDedge Dermatology
Rates of relevant counseling/education lower at dermatology vs. primary care PsA outpatient visits
MDedge Dermatology
PsA: Golimumab effective under long-term real-life clinical setting
MDedge Dermatology
Upadacitinib in a 15 mg dose could achieve robust efficacy in PsA with limited adverse events
MDedge Dermatology
Frequent treatment changes in PsA patients treated with DMARDs in routine clinical care
MDedge Dermatology